These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 25877002)

  • 1. The aggravation of mitochondrial dysfunction in nonalcoholic fatty liver disease accompanied with type 2 diabetes mellitus.
    Liu X; Zhang J; Ming Y; Chen X; Zeng M; Mao Y
    Scand J Gastroenterol; 2015; 50(9):1152-9. PubMed ID: 25877002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A moderate increase in carnitine palmitoyltransferase 1a activity is sufficient to substantially reduce hepatic triglyceride levels.
    Stefanovic-Racic M; Perdomo G; Mantell BS; Sipula IJ; Brown NF; O'Doherty RM
    Am J Physiol Endocrinol Metab; 2008 May; 294(5):E969-77. PubMed ID: 18349115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis of metabolic risk factors for developing nonalcoholic fatty liver in patients with type 2 diabetes mellitus].
    Guo M; Xi G; Yang N; Yao H
    Zhonghua Gan Zang Bing Za Zhi; 2014 Aug; 22(8):631-5. PubMed ID: 25243967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of free fatty acid-induced hepatic lipotoxicity by carnitine via reversal of mitochondrial dysfunction.
    Jun DW; Cho WK; Jun JH; Kwon HJ; Jang KS; Kim HJ; Jeon HJ; Lee KN; Lee HL; Lee OY; Yoon BC; Choi HS; Hahm JS; Lee MH
    Liver Int; 2011 Oct; 31(9):1315-24. PubMed ID: 22093454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum phospholipid omega-3 polyunsaturated fatty acids and insulin resistance in type 2 diabetes mellitus and non-alcoholic fatty liver disease.
    Lou DJ; Zhu QQ; Si XW; Guan LL; You QY; Yu ZM; Zhang AZ
    J Diabetes Complications; 2014; 28(5):711-4. PubMed ID: 24927647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial dysfunction in rat with nonalcoholic fatty liver Involvement of complex I, reactive oxygen species and cardiolipin.
    Petrosillo G; Portincasa P; Grattagliano I; Casanova G; Matera M; Ruggiero FM; Ferri D; Paradies G
    Biochim Biophys Acta; 2007 Oct; 1767(10):1260-7. PubMed ID: 17900521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hepatic SIRT1 and UCP2 expressions in rats with type 2 diabetes mellitus and nonalcoholic fatty liver].
    Xu J; Li N; Wang J; Zhang C; Ding S; Jiao Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 May; 32(5):726-9. PubMed ID: 22588935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of carnitine palmitoyltransferase (CPT) I during fasting in rainbow trout (Oncorhynchus mykiss) promotes increased mitochondrial fatty acid oxidation.
    Morash AJ; McClelland GB
    Physiol Biochem Zool; 2011; 84(6):625-33. PubMed ID: 22030855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of TangGanJian on nonalcoholic fatty liver disease with type 2 diabetes mellitus.
    Fan Y; Xiong W; Li J; Hu A; He Z; Zhang J; Zhou G; Yin Q
    Pharm Biol; 2018 Dec; 56(1):567-572. PubMed ID: 30460863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. S100A9: A Potential Biomarker for the Progression of Non-Alcoholic Fatty Liver Disease and the Diagnosis of Non-Alcoholic Steatohepatitis.
    Liu X; Wang Y; Ming Y; Song Y; Zhang J; Chen X; Zeng M; Mao Y
    PLoS One; 2015; 10(5):e0127352. PubMed ID: 25993652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between resistin +299A/A genotype and nonalcoholic fatty liver disease in Chinese patients with type 2 diabetes mellitus.
    Zhang LY; Jin YJ; Jin QS; Lin LY; Zhang DD; Kong LL
    Gene; 2013 Oct; 529(2):340-4. PubMed ID: 23954219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial effects of neomangiferin on high fat diet-induced nonalcoholic fatty liver disease in rats.
    Zhou C; Zhou J; Han N; Liu Z; Xiao B; Yin J
    Int Immunopharmacol; 2015 Mar; 25(1):218-28. PubMed ID: 25661699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mitochondrial activities of citrate synthase, carnitine palmitoyltransferase-1 and cytochrome C oxidase are increased during the apoptotic process in hepatocytes of a rat model of acute liver failure].
    Chen L; Yang B; Zhou L; Duan Z; Liu W; Ding M
    Zhonghua Gan Zang Bing Za Zhi; 2014 Jun; 22(6):456-61. PubMed ID: 25203711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonalcoholic Fatty Liver Disease: The New Complication of Type 2 Diabetes Mellitus.
    Bril F; Cusi K
    Endocrinol Metab Clin North Am; 2016 Dec; 45(4):765-781. PubMed ID: 27823604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-talk between branched-chain amino acids and hepatic mitochondria is compromised in nonalcoholic fatty liver disease.
    Sunny NE; Kalavalapalli S; Bril F; Garrett TJ; Nautiyal M; Mathew JT; Williams CM; Cusi K
    Am J Physiol Endocrinol Metab; 2015 Aug; 309(4):E311-9. PubMed ID: 26058864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cytokeratin-18 fragment level as a biomarker of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus.
    Miyasato M; Murase-Mishiba Y; Bessho M; Miyawaki M; Imbe H; Tsutsumi C; Tanimoto K; Imagawa A; Terasaki J; Hanafusa T
    Clin Chim Acta; 2014 Jun; 433():184-9. PubMed ID: 24667697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of metformin on the expression of SIRT1 and UCP2 in rat liver of type 2 diabetes mellitus and nonalcoholic fatty liver].
    Xu J; Li N; Wang J; Zhang C; Ding S; Jiao Y; Zhang J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Sep; 38(9):882-7. PubMed ID: 24071688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial carnitine palmitoyltransferase-II dysfunction: A possible novel mechanism for nonalcoholic fatty liver disease in hepatocarcinogenesis.
    Yao M; Zhou P; Qin YY; Wang L; Yao DF
    World J Gastroenterol; 2023 Mar; 29(12):1765-1778. PubMed ID: 37032731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene-metabolite network analysis in different nonalcoholic fatty liver disease phenotypes.
    Liu XL; Ming YN; Zhang JY; Chen XY; Zeng MD; Mao YM
    Exp Mol Med; 2017 Jan; 49(1):e283. PubMed ID: 28082742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of prevalence of nonalcoholic fatty liver disease (NAFLD) in type 2 diabetes patients in India (SPRINT).
    Kalra S; Vithalani M; Gulati G; Kulkarni CM; Kadam Y; Pallivathukkal J; Das B; Sahay R; Modi KD
    J Assoc Physicians India; 2013 Jul; 61(7):448-53. PubMed ID: 24772746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.